Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer

Clinical Cancer Research

Volumn 6, Issue 6, 2000, Pages 2349-2355

  Cox, Giles ^a,b   Jones, J Louise ^a   O'Byrne, Kenneth J ^b  

^a GLENFIELD HOSPITAL   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; EPIDERMAL GROWTH FACTOR; GELATINASE B;

ARTICLE; BASEMENT MEMBRANE; CANCER STAGING; CORRELATION FUNCTION; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL RATE; TRANSCRIPTION REGULATION;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL MEMBRANE; CYTOPLASM; DISEASE PROGRESSION; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SEX FACTORS; SIGNAL TRANSDUCTION; TIME FACTORS; UP-REGULATION;

EID: 0034042621     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Walker, R. A. The erb/HER type 1 tyrosine kinase receptor family. J. Pathol., 185: 234-235, 1998.
2. Hendler, F. J., and Ozanne, B. Human squamous cell lung cancers express increased epidermal growth factor receptors. J. Clin. Invest., 74: 647-651, 1984.
3. Veale, D., Kerr, N., Gibson, G. J., Kelly, P. J., and Harris, A. L. The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival. Br. J. Cancer, 68: 162-165, 1993.
4. HER-2 in patients with systematically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections. Br. J. Cancer, 74: 86-91, 1996.
5. Cox, G., Steward, W. P., and O'Byrae, K. J. The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer. Thorax, 54: 169-179, 1999.
6. Kawamata, H., Kameyama, S., Kawai, K., Tanaka, Y., Nan, L., Barch, D. H., Stetler-Stevenson, W. G., and Oyasu, R. Marked acceleration of the metastatic phenotype of a rat bladder carcinoma cell line by the expression of human gelatinase A. Int. J. Cancer, 63: 568-575, 1995.
7. Talbot, D. C., and Brown, P. D. Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer. Eur. J. Cancer, 32A: 2528-2533, 1996.
8. Sato, H., Kida, Y., Mai, M., Endo, Y., Sasaki, T., Tanaka, J., and Seiki, M. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene, 7: 77-83, 1992.
9. Muller, D., Breathnach, R., Engelmann, A., Millon, R., Bronner, G., Flesch, H., Dumont, P., Eber, M., and Abercassis, J. Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours. Int. J. Cancer, 48: 550-561, 1991.
10. Brown, P. D., Bloxidge, R. E., Stuart, N. S. A., Gatter, K. C., and Carmichael, J. Association between expression of 72-kilodalton gelatinase and tumour spread in non-small cell lung cancer. J. Natl. Cancer Inst., 85: 574-578, 1993.
11. Kodate, M., Kasai, T., Hashimoto, H., Yasumoto, K., Iwata, Y., and Manabe, H. Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung. Pathol. Int., 47: 461-469, 1997.
12. O-charoenrat, P., Modjtahedi, H., Court, W., Box, G., Ryan-Evans, P., and Eccles, S. Over-expression of epidermal growth factor receptor in human head and neck carcinoma cell lines correlates with MMP-9 expression and in vitro invasion. Br. J. Cancer, 80SII: 36, 1999.
13. World Health Organisation. The World Health Organisation histological typing of lung cancer. Am. J. Clin. Pathol., 77: 123-136, 1982.
14. Mountain, C. F. Revisions in the international system for staging lung cancer. Chest, 111: 1711-1717, 1997.
15. Rasmussen, H. S., and McCann, P. P. Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat. Pharmacol. Ther., 75: 69-75, 1997.
16. An, Z., Wang, X., Willmott, N., Chander, S. K., Tickle, S., Docherty, A. J., Mountain, A., Millican, A. T., Morphy, R., Porter, J. R., Epemolu, R. O., Kubota, T., Moossa, A. R., and Hoffman, R. M. An orally-active synthetic MMP inhibitor CT1746 reduces tumour spread and metastasis converting aggressive colonic cancer into a more indolent disease in a nude-mice model. Clin. Exp. Metastasis, 15: 184-195, 1997.
17. Fontanini, G., Vignati, S., Bigini, D., Mussi, A., Lucchi, H., Angeletti, C. A., Pingitore, R., Pepe, S., Basolo, F., and Bevilacqua, G. Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype. Eur. J. Cancer, 31A: 178-183, 1995.
18. Kondapaka, S. B., Fridman, R., and Reddy, K. B. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells. Int. J. Cancer, 70: 722-726, 1997.
19. Unemori, E. N., Ehsani, N., Wang, M., Lee, S., McGuire, J., and Amento, E. P. Interleukin-1 and transforming growth factor-α: synergistic stimulation of metalloproteinases, PGE2, and proliferation in human fibroblasts. Exp. Cell Res., 210: 166-171, 1994.
20. Reddy, K. B., Kreuger, J. S., Kondapaka, S. B., and Diglio, C. A. Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells. Int. J. Cancer, 82: 268-273, 1999.
21. Westermarck, J., and Kahari, V. M. Regulation of matrix metalloproteinase expression in tumour invasion. FASEB J., 13: 781-792, 1999.
22. Jones, J. L., Royall, J. E., and Walker, R. A. E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma. Br. J. Cancer, 74: 1237-1241, 1996.
23. Llorens, A., Rodrigo, I., Lopez-Barcons, L., Gonzalez-Garrigens, M., Lozano, E., Vinyals, A., Quintanilla, M., Cano, A., and Fabra, A. Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression. Lab. Invest., 78: 1131-1142, 1998.